A Phase 2 Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarcinoma.

Wild, A T; Chang, D T; Goodman, K A; Laheru, D A; Zheng, L; Raman, S P; Columbo, L A; Wolfgang, C L; Koong, A C; Herman, J M

Wild, A T; Chang, D T; Goodman, K A; Laheru, D A; Zheng, L; Raman, S P; Columbo, L A; Wolfgang, C L; Koong, A C; Herman, J M.

Afiliação

Wild AT; Johns Hopkins University School of Medicine, Baltimore, MD.
Chang DT; Stanford University, Stanford, CA.
Goodman KA; Memorial Sloan-Kettering Cancer Center, New York, NY.
Laheru DA; Johns Hopkins University School of Medicine, Baltimore, MD.
Zheng L; Johns Hopkins University School of Medicine, Baltimore, MD.
Raman SP; Johns Hopkins University School of Medicine, Baltimore, MD.
Columbo LA; Stanford University, Stanford, CA.
Wolfgang CL; Johns Hopkins University School of Medicine, Baltimore, MD.
Koong AC; Stanford University, Stanford, CA.
Herman JM; Johns Hopkins University School of Medicine, Baltimore, MD.

Pract Radiat Oncol ; 3(2 Suppl 1): S4-5, 2013.

Article em En | MEDLINE | ID: mdl-24674559

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article